(VIANEWS) – Vaalco Energy (EGY), Peoples Bancorp (PEBO), Kiniksa Pharmaceuticals, Ltd. (KNSA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Vaalco Energy (EGY)
43.2% sales growth and 11.25% return on equity
VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas. The company holds Etame production sharing contract related to the Etame Marin block located offshore in the Republic of Gabon, West Africa. It also owns interests in an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was founded in 1985 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Vaalco Energy has a trailing twelve months EPS of $0.37.
PE Ratio
Vaalco Energy has a trailing twelve months price to earnings ratio of 11.54. Meaning, the purchaser of the share is investing $11.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.25%.
Sales Growth
Vaalco Energy’s sales growth is 61.2% for the ongoing quarter and 43.2% for the next.
2. Peoples Bancorp (PEBO)
28.2% sales growth and 11.25% return on equity
Peoples Bancorp Inc. operates as the holding company for Peoples Bank that provides commercial and retail banking products and services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and provides commercial and industrial, commercial real estate, construction, finance, residential real estate, and consumer indirect and direct loans, as well as home equity lines of credit and overdrafts. It also offers debit and automated teller machine (ATM) cards; safe deposit rental facilities; money orders and cashier's checks; and telephone, mobile, and Internet-based banking services. In addition, the company provides various life, health, and property and casualty insurance products; third-party insurance administration; insurance premium financing; commercial and technology equipment leasing; fiduciary and trust; underwriting, origination and servicing of equipment leases, and equipment financing agreements; and asset management and administration services, as well as employee benefit, retirement, and health care plan administration services. Further, it offers brokerage services through an unaffiliated registered broker-dealers; insurance premium finance lending and lease financing services; and credit cards to individuals and businesses, as well as provides merchant credit card transaction processing, and person-to-person payment processing services. The company operates through 135 financial service offices and ATMs, including 119 full-service branches in Ohio, West Virginia, Kentucky, Virginia, Washington, D.C., and Maryland. Peoples Bancorp Inc. was founded in 1902 and is based in Marietta, Ohio.
Earnings Per Share
As for profitability, Peoples Bancorp has a trailing twelve months EPS of $3.44.
PE Ratio
Peoples Bancorp has a trailing twelve months price to earnings ratio of 7.38. Meaning, the purchaser of the share is investing $7.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.25%.
Moving Average
Peoples Bancorp’s value is under its 50-day moving average of $26.48 and under its 200-day moving average of $27.23.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 360.71M for the twelve trailing months.
3. Kiniksa Pharmaceuticals, Ltd. (KNSA)
15.5% sales growth and 81.84% return on equity
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months EPS of $3.36.
PE Ratio
Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months price to earnings ratio of 5.1. Meaning, the purchaser of the share is investing $5.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 81.84%.
4. Rockwell Automation (ROK)
14.3% sales growth and 44.65% return on equity
Rockwell Automation, Inc. provides industrial automation and digital transformation solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments, Intelligent Devices, Software & Control, and Lifecycle Services. Its solutions include hardware and software products and services. The Intelligent Devices segment offers drives, motion, safety, sensing, industrial components, and configured-to-order products. The Software & Control segment provides control and visualization software and hardware, information software, and network and security infrastructure solutions. The Lifecycle Services segment provides consulting, professional services and solutions, and connected and maintenance services. The company sells its solutions primarily through independent distributors in relation with its direct sales force. It serves discrete end markets, including automotive, semiconductor, and warehousing and logistics, as well as general industries comprising printing and publishing, marine, glass, fiber and textiles, airports, and aerospace; hybrid end markets, such as food and beverage, life sciences, household and personal care, and tire, as well as eco industrial, including water/wastewater, waste management, mass transit, and renewable energy; and process end markets comprising oil and gas, mining, metals, chemicals, pulp and paper, and others. Rockwell Automation, Inc. was founded in 1903 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Rockwell Automation has a trailing twelve months EPS of $12.24.
PE Ratio
Rockwell Automation has a trailing twelve months price to earnings ratio of 23.16. Meaning, the purchaser of the share is investing $23.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.65%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 10, 2023, the estimated forward annual dividend rate is 4.72 and the estimated forward annual dividend yield is 1.65%.
Yearly Top and Bottom Value
Rockwell Automation’s stock is valued at $283.49 at 20:22 EST, way under its 52-week high of $348.52 and way higher than its 52-week low of $217.59.
Volume
Today’s last reported volume for Rockwell Automation is 329175 which is 55.98% below its average volume of 747914.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Rockwell Automation’s EBITDA is 73.4.
5. TJX Companies (TJX)
11.5% sales growth and 66.32% return on equity
The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer in the United States, Canada, Europe, and Australia. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. The company sells family apparel, including footwear and accessories; home fashions, such as home basics, furniture, rugs, lighting products, giftware, soft home products, decorative accessories, tabletop, and cookware, as well as expanded pet, and gourmet food departments; jewelry and accessories; and other merchandise. The TJX Companies, Inc. was incorporated in 1962 and is headquartered in Framingham, Massachusetts.
Earnings Per Share
As for profitability, TJX Companies has a trailing twelve months EPS of $3.41.
PE Ratio
TJX Companies has a trailing twelve months price to earnings ratio of 25.99. Meaning, the purchaser of the share is investing $25.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 66.32%.
Volume
Today’s last reported volume for TJX Companies is 1921820 which is 60.2% below its average volume of 4828750.
Previous days news about TJX Companies(TJX)
- TJX companies (tjx) gains from business strength amid risks. According to Zacks on Monday, 2 October, "With the growing popularity of online shopping among consumers, The TJX Companies has undertaken several initiatives to boost online sales and strengthen its e-commerce business. ", "The TJX Companies also operates in the highly competitive retail apparel and home fashion industry. "
6. Credicorp Ltd. (BAP)
9.5% sales growth and 18.2% return on equity
Credicorp Ltd., a financial services holding company, provides various financial, insurance, and health services and products primarily in Peru and internationally. The company's Universal Banking segment offers deposits and current accounts, and various credits and financial instruments to individuals and legal entities. Its Insurance and Pensions segment issues insurance policies to cover losses in commercial property, transportation, marine vessels, automobile, life, health, and pensions, as well as provides private pension fund management services. The company's Microfinance segment manages loans, credits, deposits, and current accounts of the small and microenterprises. Its Investment Banking and Wealth Management segment offers its services to corporations, institutional investors, governments, and foundations; engages in structuring and placement of issues in the primary market, as well as the execution and negotiation of operations in the secondary market; and structures securitization processes for corporate customers and manages mutual funds. The company was founded in 1889 and is headquartered in Lima, Peru.
Earnings Per Share
As for profitability, Credicorp Ltd. has a trailing twelve months EPS of $16.92.
PE Ratio
Credicorp Ltd. has a trailing twelve months price to earnings ratio of 7.98. Meaning, the purchaser of the share is investing $7.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.2%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 6.77 and the estimated forward annual dividend yield is 4.98%.
